Prof.Dr. Ponlapat Rojnuckarin

Consultant

34 Years of Experience

Hematologist

MD, Diploma, Fellowship, PhD

Bumrungrad International Hospital, Bangkok

English, Thai

Consultation Fee $ 29

Book Appointment

About Prof.Dr. Ponlapat Rojnuckarin

Dr. Ponlapat Rojnuckarin is a hematologist with over 34 years of experience in managing blood disorders.
He is known for treating various hematologic conditions, including bleeding disorders, anemia, and clotting abnormalities.
He graduated with an MD from the Faculty of Medicine at Chulalongkorn University in Thailand in 1990.
Dr. Ponlapat Rojnuckarin earned a Diploma from the Thai Board of Internal Medicine in 1994 and a Diploma from the Thai Board of Hematology in 1996.
He further completed his PhD in Molecular Biology of Blood Cell Development at the University of Washington, Seattle, USA, in 2001.
In 1996, he completed a Fellowship in Hematology at Chulalongkorn University.

Book Your Appointment With Prof.Dr. Ponlapat Rojnuckarin

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Query

Education

MD, Faculty of Medicine, Chulalongkorn University, Thailand, 1990
Diploma from the Thai Board of Internal Medicine, 1994
Diploma from the Thai Board of Hematology, 1996
Fellowship in Hematology, Chulalongkorn University, 1996
PhD in Molecular Biology of Blood Cell Development, University of Washington, Seattle, USA, 2001

Paper Published

Iam-Arunthai, K., Chamnanchanunt, S., Thungthong, P., Intalapaporn, P., Nakhahes, C., Suwanban, T., & Rojnuckarin, P. (2024). Thrombosis and Bleeding Risk Scores Are Strongly Associated with Mortality in Hospitalized Patients with COVID-19: A Multicenter Cohort Study. Journal of Clinical Medicine, 13(5), 1437.
Chuansumrit, A., Ruchutrakul, T., Sirachainan, N., Kitpoka, P., Panuwannakorn, M., Panburana, P., Suwannuraks, M., Sri-Udomporn, N., Kijkunasathian, C., Jaovisidha, S., Utamakul, C., Natesirinilkul, R., Pongtanakul, B., Traivaree, C., Komvilaisak, P., Suwantaroj, E., Sosothikul, D., Angchaisuksiri, P., & Rojnuckarin, P. (2023). National strategic advocacy to manage patients with inherited bleeding disorders in low and lower-middle-income countries. Expert Review of Hematology, 16(12), 1063–1076.
Jutiamornlerd, S., Uaprasert, N., & Rojnuckarin, P. (2023). Good Prognosis of Adult Immune Thrombocytopenia in a Provincial Hospital. Blood, 142(Supplement 1), 7297.
Cherdchoo, N., Polprasert, C., Rojnuckarin, P., & Kongkiatkamon, S. (2023). Clinical characteristics and symptom burden of Thai myeloproliferative neoplasm patients. Hematology, 28(1).
Limwongse, C., Rojnuckarin, P., Kupatawintu, P., Thongthaisin, A., Permpikul, P., Kitpoka, P., Watanaboonyongcharoen, P., Sucharitchan, P., Torcharus, K., Fucharoen, S., Kongpakwattana, K., Nerapusee, O., & Chuncharunee, S. (2023). How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework? Transfusion Medicine, 33(6), 497–502.
Boonyabaramee, P., Polprasert, C., Kobbuaklee, S., Settapiboon, R., Pongudom, S., Faknuam, S., Kongkiatkamon, S., Wudhikarn, K., & Rojnuckarin, P. (2023). Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation. Experimental Hematology, 125–126, 20-24.e4.